January 24, 2022
Elon Musk’s startup company, which aims to connect people’s brains to computers, announces after a director of clinical trials, a sign that the company is ready to start testing with humans.
The job description from Neuralink states that the position is based in Fremont, California, and that the employee will “work closely with some of the most innovative physicians and top engineers” as well as with Neuralink’s first clinical trial participants. One key qualification listed for the job is managing FDA interactions.
The Neuralink website says the “neural implant” would let a person control a computer, keyboard or mobile device “just by thinking about it.”
An implant or link that stimulates and transmits neural signals would be transplanted into a person’s brain by a robotic system controlled by a neurosurgeon, the company’s website says. The link is connected to flexible micron-scale wires that contain electrodes inserted into parts of the brain that control movement.
The company’s first goal is to help paralyzed people regain their independence by gaining control of computers and mobile devices.
Musk told Wall Street Journal’s CEO Council summit last month where Neuralink hoped to implant microchips in humans by 2022.
“Neuralink works well in monkeys, and we’re actually just doing a lot of testing and just confirming that it’s very safe and reliable, and the Neuralink device can be removed safely,” Musk said.
“We hope to have this in our first humans – who will be people who have severe spinal cord injuries like tetraplegics, quadriplegics – next year, awaiting FDA approval.”
Musk, the founder of Telsa and Space Explorations Technology Inc., launched Neuralink in 2017.
In 2019, he announced that Neuralink was almost ready to begin clinical trials with humans, but failed to do so at the time, USA Today reported.